G1 Therapeutics Cash from Financing (TTM) Analysis

G1 Therapeutics Inc (GTHX)

4.485 +0.04 (+1.01%) USD | NASDAQ | May 03, 16:00

4.58 +0.10 (+2.12%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2016. Upgrade now.

Date	Value
December 31, 2023	-26.91M
September 30, 2023	25.40M
June 30, 2023	25.51M
March 31, 2023	52.26M
December 31, 2022	52.50M
September 30, 2022	43.90M
June 30, 2022	45.86M
March 31, 2022	47.34M
December 31, 2021	145.86M
September 30, 2021	102.58M
June 30, 2021	100.78M
March 31, 2021	120.01M
December 31, 2020	21.69M
September 30, 2020	21.60M
June 30, 2020	22.69M

Date	Value
March 31, 2020	2.655M
December 31, 2019	2.705M
September 30, 2019	2.424M
June 30, 2019	220.57M
March 31, 2019	232.01M
December 31, 2018	340.49M
September 30, 2018	340.59M
June 30, 2018	120.77M
March 31, 2018	216.36M
December 31, 2017	107.32M
September 30, 2017	107.12M
June 30, 2017	107.42M
March 31, 2017	49.47M
December 31, 2016	49.76M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-26.91M

Minimum

Dec 2023

220.57M

Maximum

Jun 2019

54.18M

Average

43.90M

Median

Sep 2022

Cash from Financing (TTM) Benchmarks